BRAIN

EQS-News: Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams

Retrieved on: 
Wednesday, April 10, 2024
Climate change, Education, Drink, TVC, BRAIN, Food, Plant, Wine, Applied science, BMBF

Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams

Key Points: 
  • Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
    The issuer is solely responsible for the content of this announcement.
  • The aim of the “SusBev” project is to use and ferment agricultural residues and side streams from viticulture and other regional agricultural processes to produce healthy and tasty beverages and food.
  • In addition, their resistance to fungal attack means that the plants require less pesticide treatment, making them safe for consumption.
  • BRAIN Biotech AG, Tropical Viticulture Consultants (TVC), Zukunftsweine GmbH (ZW) and Provadis Hochschule are participating in the SusBev project.

DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI

Retrieved on: 
Wednesday, April 3, 2024
Health, Brain, Dementia, Sport, Intelligence, BRAIN, Mental health, Research, University, Hamilton Health Sciences, Drexel University

The Company continues to expand its commercial initiatives in the U.S. and Canada for its CERVAI™ Brain Health AI Platform, which includes the BRAIN AGE® estimation solution, with world-class clinicians and hospital facilities such as the University of Miami Comprehensive Center for Brain Health, and in Canada’s leading research hospitals, such as Hamilton Health Sciences and St. Joe’s Healthcare Hamilton.

Key Points: 
  • The Company continues to expand its commercial initiatives in the U.S. and Canada for its CERVAI™ Brain Health AI Platform, which includes the BRAIN AGE® estimation solution, with world-class clinicians and hospital facilities such as the University of Miami Comprehensive Center for Brain Health, and in Canada’s leading research hospitals, such as Hamilton Health Sciences and St. Joe’s Healthcare Hamilton.
  • CERVAI™ Brain Health AI Platform is a world-first consumer brain health and wellness AI solution that estimates BRAIN AGE® and provides a brain health score.
  • Based on research and development at Drexel University and the University of Miami, CERVAI™ combines a BRAIN AGE® Estimation and Brain Health Assessment tool with the aim to ‘raise a red flag’ for potential brain health issues.
  • Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions.

DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO

Retrieved on: 
Wednesday, March 20, 2024
Health, Brain, Dementia, Sport, Acceleration, Intelligence, BRAIN, Mental health, Research, CIPO, University, Hamilton Health Sciences, Drexel University

The CERVAI™ Brain Health commercial pilot program is available to clinics in Canada and the U.S.

Key Points: 
  • The CERVAI™ Brain Health commercial pilot program is available to clinics in Canada and the U.S.
  • CERVAI™ Brain Health AI Platform is a world-first consumer brain health and wellness AI solution that estimates BRAIN AGE® and provides a brain health score.
  • Based on research and development at Drexel University and the University of Miami, CERVAI™ combines a BRAIN AGE® Estimation and Brain Health Assessment tool with the aim to ‘raise a red flag’ for potential brain health issues.
  • Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions.

WorldQuant Commences 2024 International Quant Championship

Retrieved on: 
Tuesday, March 19, 2024
Software, Asset Management, Consulting, Artificial Intelligence, Data Management, Professional Services, Technology, Other Technology, Algorithm, University, Data science, Environment, IQC, BRAIN, Knowledge, WorldQuant, Research, AI, McMaster University, Student, Machine learning, Multimedia, Consultant

WorldQuant, a global quantitative asset management firm, today announced the launch of its flagship International Quant Championship (IQC) for 2024, a three-stage, team-based competition engaging students, academia and professionals from around the globe.

Key Points: 
  • WorldQuant, a global quantitative asset management firm, today announced the launch of its flagship International Quant Championship (IQC) for 2024, a three-stage, team-based competition engaging students, academia and professionals from around the globe.
  • View the full release here: https://www.businesswire.com/news/home/20240319558098/en/
    The 2024 IQC, which takes place on WorldQuant’s BRAIN platform, builds on existing competitions hosted by WorldQuant and encourages talent from eligible regions and across experience levels to participate.
  • More than 60 past BRAIN consultants have subsequently become full-time employees at WorldQuant since inception of the platform.
  • 1 WorldQuant defines “Alphas” as mathematical models that seek to predict the future price movements of various financial instruments.

Privacy and the Rise of “Neurorights” in Latin America

Retrieved on: 
Tuesday, April 2, 2024
Algorithm, LGPD, Artificial intelligence, Parliament, Constitution, Neuroprivacy, Spanish, Rise, Emotion, EEG, Civil code, Congress, MRI, Initiative, BRAIN, Emotiv, Policy, Initialization (programming), UNESCO, Ferhat Ozcep, OECD, Brazilian, Supreme court, Confidentiality, Safety, Language, Latin American Parliament, Senate, State, Rapporteur, Digital, Magnetic resonance imaging, Constitution of Brazil, Research, Peripheral nervous system, AI, Economy, RIPD, Health, Brain, Network, Trust, Record, Organization, Spinal cord, Traction, Electroencephalography, Court

Authors: Beth Do, Maria Badillo, Randy Cantz, Jameson Spivack “Neurorights,” a set of proposed rights that specifically protect mental freedom and privacy, have captured the interest of many governments, scholars, and advocates. Nowhere is that more apparent than in Latin America, where several countries are actively seeking to enshrine these rights in law, and some [?]

Key Points: 


Authors: Beth Do, Maria Badillo, Randy Cantz, Jameson Spivack “Neurorights,” a set of proposed rights that specifically protect mental freedom and privacy, have captured the interest of many governments, scholars, and advocates. Nowhere is that more apparent than in Latin America, where several countries are actively seeking to enshrine these rights in law, and some [?]

EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG

Retrieved on: 
Wednesday, March 13, 2024
MBG, Annual general meeting, Architecture, Supervisory board, Gesellschaft mit beschränkter Haftung, IPO, EUR, Frankfurt Stock Exchange, BRAIN, Annual, Speech, Research

Zwingenberg, Germany, 12 March 2024 – At today´s Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), the shareholders approved all items on the agenda with a clear majority.

Key Points: 
  • Zwingenberg, Germany, 12 March 2024 – At today´s Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), the shareholders approved all items on the agenda with a clear majority.
  • The establishment of silent partnerships between BRAIN Biotech AG and Hessen Kapital I GmbH and MBG H Mittelständische Beteiligungsgesellschaft Hessen mbH - for the financing of innovative research projects at the locations in Hesse - received approval rates of over 99% in each case.
  • 65,99 % of the share capital was represented at the time of the voting.
  • In his speech to shareholders, CEO Adriaan Moelker said: "We now have the architecture, the employees, the technology, the customers and the products to further accelerate our economic success.

EQS-News: BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives

Retrieved on: 
Wednesday, March 13, 2024
CFO, Supervisory board, EUR, AGM, MP, BRAIN, Security (finance)

The initial conversion price of EUR 5.04 was set with a conversion premium of 27 % above the reference share price of EUR 3.97.

Key Points: 
  • The initial conversion price of EUR 5.04 was set with a conversion premium of 27 % above the reference share price of EUR 3.97.
  • BRAIN Biotech AG intends to use the net issue proceeds for the financing of growth initiatives and general corporate financing purposes.
  • Adriaan Moelker, CEO BRAIN Biotech AG, stated: “I would like to thank our anchor shareholder, MP-Beteiligungs-GmbH, for their continued support on our growth path.
  • These statements reflect the current views, expectations, and assumptions of the management of BRAIN Biotech AG, and are based on information currently available to the management.

EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

Retrieved on: 
Wednesday, March 13, 2024
AMSilk, Protein engineering, A-DNA, AI, Research and development, Molecular biology, PCT, Gold, Gel, Microplastics, CO2, BRAIN, Partnership, Fine chemical

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

Key Points: 
  • Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
    The issuer is solely responsible for the content of this announcement.
  • Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
    Zwingenberg / Neuried (Germany), March 5, 2024 - BRAIN Biotech AG, leading provider of solutions for the biologization of industry, and AMSilk GmbH, a global leader in advanced materials made from spider silk-based proteins, announce the successful completion of the first phase of a development collaboration.
  • The success of this strategic R&D collaboration is based on the use of BRAIN Biotech’s rational design in protein engineering.
  • With their years of protein engineering expertise and with our common vision, BRAIN Biotech is an ideal fit as a development partner.”

EQS-News: 3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24

Retrieved on: 
Wednesday, March 13, 2024
Bioproduct, BioScience, Enzyme, Research, Investment, Growth, Genomics, Protein, FY, BRAIN, Business, Fine chemical

Adriaan Moelker, CEO BRAIN Biotech AG, states: “Our BioScience segment made a very strong start to the business year.

Key Points: 
  • Adriaan Moelker, CEO BRAIN Biotech AG, states: “Our BioScience segment made a very strong start to the business year.
  • The BRAIN Biotech Holding segment mainly includes personnel expenses and other expenses for Group administration, further development of the BRAIN Biotech Group, stock exchange listing and M&A activities.
  • CFO at BRAIN Biotech AG, Michael Schneiders, takes an optimistic view on the financial year 2023/24: “We aim to continue our organic growth path from the last two years.
  • The BRAIN Biotech Group now targets a revenue range of € 58 million to € 62 million for the new financial year.

As the Popularity of Children-Focused Companies Rise, Kids 'R' Kids Celebrates 39 Years and 170 Franchise Locations

Retrieved on: 
Thursday, February 22, 2024
Language, Kid, Problem solving, Art, Curriculum, STEAM, Mevalonate pathway, BRAIN, Learning, Toy

Kids 'R' Kids Acknowledged as a Top Franchise Opportunity in Billion-Dollar Childcare and Early Education Industry

Key Points: 
  • "Kids 'R' Kids is our opportunity to support our industry's needs with a strong and structured educational program," he says.
  • The Kids 'R' Kids STEAM AHEAD program incorporates Science, Technology, Engineering, Art, and Math into children's daily learning, through play.
  • The Learning Academies provide BRAIN WAVES activities every day, with an emphasis on one of the brain's four lobes on their own.
  • As the nation's priority on early education rises, Kids 'R' Kids looks forward to continued development and expansion of its 170 locations in 2024 and beyond.